[Conclusions from the clinical trials of TachoComb, a hemostatic]

Rozhl Chir. 1996 Apr;75(4):216-8.
[Article in Czech]

Abstract

The authors present a report on their very favourable experience assembled during clinical tests of a new haemostatic TachoComb of the company HAFSLUND NYCOMED PHARMA AG Linz Austria which were made at their department before the preparation was introduced in the Czech Republic. Despite the high price the authors recommend that the preparation should be available in every operation theatre in particular for haemostasis of injured parenchymatous organs.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Aprotinin*
  • Clinical Trials as Topic
  • Drug Combinations
  • Female
  • Fibrinogen*
  • Hemostasis, Surgical*
  • Hemostatics*
  • Humans
  • Male
  • Middle Aged
  • Thrombin*

Substances

  • Drug Combinations
  • Hemostatics
  • tachocomb
  • Fibrinogen
  • Aprotinin
  • Thrombin